Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).
暂无分享,去创建一个
Susan M. Chang | M. Prados | M. Mehta | L. Deangelis | H. Fine | K. Lamborn | N. Butowski | F. Iwamoto | L. Abrey | H. Robins | Wei-Ting Zhang